<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02069587</url>
  </required_header>
  <id_info>
    <org_study_id>0074-13HYMC</org_study_id>
    <nct_id>NCT02069587</nct_id>
  </id_info>
  <brief_title>Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes</brief_title>
  <official_title>Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preterm premature rupture of membrane is associated with increased oxidative stress and
      inflammatory process, enhancing the activity or the availability of antioxidants may modulate
      the inflammatory response associated with PPROM, thereby reducing oxidative stress and the
      risk to the fetus. In this study the investigators sought to determine the effects of
      Pomegranate 1. On the patients (maternal and fetal) oxidative stress and inflammation
      associated with PPROM. 2. On the time interval from PPROM to delivery and on the patients
      (fetal )Ph and apger scores
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators sought to determine the effects of Pomegranate 1. On the
      patients (maternal and fetal )oxidative stress and inflammation associated with PPROM. 2. On
      the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal and fetal oxidative stress</measure>
    <time_frame>10 weeks</time_frame>
    <description>Maternal and fetal oxidative stress will be determined by blood tests.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal and fetal oxidative stress</measure>
    <time_frame>10 weeks</time_frame>
    <description>Maternal blood and umbilical cord blodd will be drawn following delivery and oxidative blood markers inflammatory mediators will be assessed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time interval from PPROM to delivery</measure>
    <time_frame>10 weeks</time_frame>
    <description>Time interval from PPROM to delivery, respiratory distress syndrome (RDS), meconium aspiration syndrome, asphyxia, late onset neonatal sepsis, hypoglycemia, necrotizing enterocolitis, hyperbilirubinemia, intraventricular hemorrhage, periventricular leucomalacia, convulsions, other neurological abnormalities, other complications, intrapartum death, total length of hospital stay and admission, and length of stay on neonatal intensive care unit (NICU).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time interval from PPROM to delivery</measure>
    <time_frame>10 weeks</time_frame>
    <description>following birth the time interval from PPROM to delivey will be assessed, also RDS, fetal Ph and other neonatal complications</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>PPROM</condition>
  <arm_group>
    <arm_group_label>Pomegranate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The women in this group will drink pomegranate juice</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>pomegranate</intervention_name>
    <arm_group_label>Pomegranate</arm_group_label>
    <other_name>Pomegranate juice</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant patients

          -  admitted with PPROM

          -  between 24-32 weeks of gestation

        Exclusion Criteria:

          -  Women with contractions

          -  abruption

          -  monochorionic multiple pregnancy

          -  abnormal (non-reassuring) cardiotocogram

          -  meconium-stained amniotic fluid

          -  signs of intrauterine infection

          -  major fetal anomalies

          -  hemolysis

          -  elevated liver enzymes

          -  low platelets (HELLP syndrome); or severe preeclampsia.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ron beloosesky</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical center technion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ron beloosesky, M.D</last_name>
    <phone>011972509205759</phone>
    <email>tomor2304@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ron Balosesky, MD</last_name>
      <phone>972509205759</phone>
      <email>tomor2304@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2014</study_first_submitted>
  <study_first_submitted_qc>February 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2014</study_first_posted>
  <last_update_submitted>February 20, 2014</last_update_submitted>
  <last_update_submitted_qc>February 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PPROM</keyword>
  <keyword>PREGNANCY</keyword>
  <keyword>POMEGRANATE</keyword>
  <keyword>OXIDATIVE STRESS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

